stearylamine has been researched along with HIV in 2 studies
*HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baier, A; Cova, L; Hosmane, RS; Zhang, N; Zhang, P | 1 |
Afzal, SM; Kishan, V; Kumar, PU; Prabhakar, K; Rajanna, A | 1 |
2 other study(ies) available for stearylamine and HIV
Article | Year |
---|---|
Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.
Topics: Antiviral Agents; Azepines; DEAD-box RNA Helicases; Dose-Response Relationship, Drug; Hepacivirus; HIV; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2014 |
Brain delivery of transferrin coupled indinavir submicron lipid emulsions--pharmacokinetics and tissue distribution.
Topics: Amines; Animals; Brain; Chromatography, Gel; Drug Carriers; Drug Stability; Emulsions; Fluorescent Dyes; HIV; HIV Infections; HIV Protease Inhibitors; Indinavir; Lipids; Male; Mice; Microscopy, Fluorescence; Microtomy; Particle Size; Receptors, Transferrin; Tissue Distribution; Transferrin | 2011 |